Zenotech Laboratories has informed that it enclosed the Integrated Filing (Financial) for the quarter and nine months ended December 31, 2024, as follows: Financial Results -Attached hereunder; Statement on deviation/variation in utilization of funds raised -Not Applicable; Outstanding default on loans and debt securities -Not Applicable.
The above information is a part of company’s filings submitted to BSE.